A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
Richard Armstrong, head of registries at NEC Software Solutions UK, puts real-world evidence under the microscope and examines how, as our population ages it has the power to speed up medical interventions at scale.
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Professor Freimut Schliess, Director of Science & Innovation, at the Profil Institut für Stoffwechselforschung GmbH, illustrates how dissipating initial scepticism of digital health technologies makes for a thrilling challenge for regulators, manufacturers and clinical researchers alike.
McLean Hospital’s Clinical and Translational Pain Research Laboratory is one of five institutions splitting a $1.67 million NIH grant - the research will examine any links between the menstrual cycle and the COVID vaccine.
The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.
